Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.

ABSTRACT:

Background

Triptans are the most commonly prescribed acute treatments for migraine; however, not all triptan users experience adequate response. Information on real-world resource use and costs associated with triptan insufficient response are limited.

Methods

A retrospective claims analysis using US commercial health plan data between 2012 and 2015 assessed healthcare resource use and costs in adults with a migraine diagnosis newly initiating triptans. Patients who either did not refill triptans but used other non-triptan medications or refilled triptans but also filled non-triptan medications over a 24-month follow-up period were designated as potential triptan insufficient responders. Patients who continued filling only triptans (i.e. triptan-only continuers) were designa

SUBMITTER: Marcus SC 

PROVIDER: S-EPMC7273744 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature